ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

Millers Win Bristol-Myers $25,000 Award

May 19, 1978

Herceptin Lowers Recurrence In Early Breast Cancer

November 25, 2005

Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer

December 27, 2002

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

March 5, 1993

U.S., Japan Establish Joint AIDS Panel

August 14, 1987

House Approves $619M Increase For NIH.

February 2, 2007